Program Schedule

48484
Introductory Remarks and Awards

Session: Plenary Session: Special Plenary Session: Resource-Limited Health Care Issues
Wednesday, October 8, 2014: 4:30 PM
Room: The Pennsylvania Convention Center: Terrace Ballroom-I, II, III, IV
David W. Kimberlin, MD, FIDSA, Pediatrics, University of Alabama At Birmingham, Birmingham, AL

Dr. David Kimberlin holds the Sergio Stagno Endowed Chair in Pediatric Infectious Diseases at the University of Alabama at Birmingham, where he is Co-Director of the Division of Pediatric Infectious Diseases. Dr. Kimberlin is Principal Investigator (PI) of the Collaborative Antiviral Study Group (CASG), and is the PI on the CASG’s four newly awarded contracts of $19.2M from NIH/NIAID/DMID to evaluate novel therapeutic and diagnostic opportunities for management of neonatal herpes simplex virus (HSV) disease and congenital cytomegalovirus (CMV) infection. These studies will involve approximately 20 academic medical centers in the Unites States and Great Britain, and will build upon previous CASG studies conducted by Dr. Kimberlin that have defined the standard of care for the treatment of neonatal HSV and congenital CMV infections. Other CASG investigations led by Dr. Kimberlin defined the worldwide management of infants with influenza disease during the 2009 H1N1 pandemic, and have investigated experimental therapies for neonatal enteroviral disease and laryngeal papillomatosis. Dr. Kimberlin is Editor of the 2015 AAP Report of the Committee on Infectious Diseases (Red Book), and was Associate Editor for the 2009 and 2012 editions. He served as a member of the American Academy of Pediatrics (AAP) Committee on Infectious Diseases (COID) from 2005-2011. For the past seven years, Dr. Kimberlin also has been the AAP Red Book liaison to the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). During this time, he has served as the COID liaison to six different ACIP Working Groups. Dr. Kimberlin is President-Elect of the Pediatric Infectious Diseases Society (PIDS), which is the world's largest organization of professionals dedicated to the treatment, control, and eradication of infectious diseases affecting children. Dr. Kimberlin also serves as the Director of Subspecialty Medical Education for the UAB Department of Pediatrics.



Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek